Bavarian Nordic, the only firm to have an approved monkeypox vaccine and that is used currently can increase its market capitalisation from the current circa 3 billion USD to 70 billion USD, I think.
Monkeypox is spreading fast and if contracted it can have a devastating effect on the organism of human beings.
Countries the world over are too slow to respond to the monkeypox threat, which increases the fear factor and raises the probability of a global, deadly monkeypox virus pandemic.
No comments:
Post a Comment